ARDSLEY ADVISORY PARTNERS LP - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
ARDSLEY ADVISORY PARTNERS LP ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$5,709,450
-48.3%
85,000
-46.9%
1.28%
-31.7%
Q2 2023$11,044,800
+27.3%
160,000
-11.1%
1.87%
-2.1%
Q1 2023$8,679,600
+94.8%
180,000
+122.2%
1.91%
+160.2%
Q2 2022$4,455,00081,0000.73%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 814,586$56,230,87217.46%
Paradigm Biocapital Advisors LP 1,805,717$124,648,6459.63%
HHLR ADVISORS, LTD. 6,436,533$444,313,8739.46%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,123,692$77,568,4599.09%
RA Capital Management 6,264,707$432,452,7248.16%
Tri Locum Partners LP 116,768$8,060,4953.00%
Nicholas Investment Partners, LP 593,167$40,946,3182.80%
E Fund Management (Hong Kong) Co., Ltd. 51,679$3,5672.66%
Avidity Partners Management LP 798,900$55,148,0671.93%
Boxer Capital, LLC 600,000$41,4181.92%
View complete list of LEGEND BIOTECH CORP shareholders